ArticleMolecular cancer therapeutics2021

A Biparatopic Antibody-Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade.

John O DaSilva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.